Novolin n and Rashes - a phase IV clinical study of FDA data

Summary:

Rashes is reported as a side effect among people who take Novolin n (insulin susp isophane semisynthetic purified human), especially for people who are male, 60+ old, have been taking the drug for 5 - 10 years also take Novolin R, and have Type 2 diabetes.

The phase IV clinical study analyzes which people have Rashes when taking Novolin n. It is created by eHealthMe based on reports of 2,495 people who have side effects when taking Novolin n from the FDA, and is updated regularly.

What is Novolin n?

Novolin n has active ingredients of insulin susp isophane semisynthetic purified human. It is often used in diabetes. eHealthMe is studying from 2,535 Novolin n users. Check the latest studies of Novolin n.

What is Rashes?

Rashes (redness) is found to be associated with 3,713 drugs and 6,213 conditions by eHealthMe. Check the latest studies of Rashes.

On Jul, 11, 2026

2,495 people reported to have side effects when taking Novolin n.
Among them, 58 people (2.32%) have Rashes.

Among these 58 people:

How long have people been on Novolin n when they have Rashes? *

What is the gender of people who have Rashes when taking Novolin n? *

female: 49.12 %
male: 50.88 %

What is the age of people who have Rashes when taking Novolin n? *

What are other drugs people take besides Novolin n? *

What are other side effects people have besides Rashes? *

Blood Glucose Increased: 11 people, 18.97%
Diarrhea: 10 people, 17.24%
Itching: 8 people, 13.79%
Weight Decreased: 7 people, 12.07%
Dizziness: 7 people, 12.07%
Peripheral Swelling: 7 people, 12.07%
Insomnia (sleeplessness): 5 people, 8.62%
Fatigue (feeling of tiredness): 5 people, 8.62%
Dyspnea (difficult or laboured breathing): 4 people, 6.90%
Headache (pain in head): 4 people, 6.90%

What are the existing conditions these people have? *

Type 2 Diabetes: 18 people, 31.03%
Nephrogenic Anaemia (anaemia due to kidney disease): 3 people, 5.17%
Anaemia (lack of blood): 3 people, 5.17%
Multiple Myeloma (cancer of the plasma cells): 3 people, 5.17%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 3 people, 5.17%
Dry Skin: 2 people, 3.45%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 3.45%
High Blood Cholesterol: 2 people, 3.45%
Acute Myocardial Infarction (acute heart attack): 2 people, 3.45%
Pain: 2 people, 3.45%

* Approximation only. Some reports may have incomplete information.

Do you take Novolin n and have Rashes?

- Check whether Rashes is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Novolin n:

Novolin n (2,535 reports)

Rashes treatments and more:

Rashes (702,909 reports)

How severe was Rashes and when was it recovered:

Rashes in Novolin n

Expand to all the drugs that have ingredients of insulin susp isophane semisynthetic purified human:

Rashes and drugs with ingredients of insulin susp isophane semisynthetic purified human (80 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Novolin n:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Rashes:

Rashes (3,713 drugs)

Browse all the conditions that are associated with Rashes:

Rashes (6,213 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on insulin susp isophane semisynthetic purified human (the active ingredients of Novolin n) and Novolin n (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.